GNUBIOTICS SCIENCES
GNUBiotics is developing a compound to reproduce the natural diversity and complexity of unique structures found in breast milk. These structures are beneficial in preventing infections and the onset of diet-induced obesity. It aims at feeding the microbiome. In response to the rising demand for healthier foods they are developing functional and structural mimics of Human Milk Oligosaccharides, (HMOs) for the consumer health market. Their products reproduce the natural diversity and complexity of HMOs and have been shown to be beneficial in preventing the onset of gut infection and protect against the effect of antibiotic use.
GNUBIOTICS SCIENCES
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2016-01-01
Address:
Epalinges, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.gnubiotics.com
Total Employee:
1+
Status:
Active
Contact:
+41 79 906 92 27
Email Addresses:
[email protected]
Total Funding:
6.12 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Apache
Similar Organizations
Arima Genomics
Arima Genomics is a biotechnology company that develops solutions to drive genomics discovery.
Cellectis
Cellartis AB is a biotechnology company based in Sweden.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Watchmaker Genomics
Watchmaker Genomics is a biotechnology company that focuses on breakthrough applications for reading, writing, and editing DNA.
Current Employees Featured
Founder
Investors List
UBS
UBS investment in Debt Financing - Gnubiotics Sciences
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Gnubiotics Sciences
Venture Kick
Venture Kick investment in Grant - Gnubiotics Sciences
Venture Kick
Venture Kick investment in Grant - Gnubiotics Sciences
Official Site Inspections
http://www.gnubiotics.com
- Host name: h2web56.infomaniak.ch
- IP address: 83.166.138.4
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "Gnubiotics Sciences"
Gnubiotics | Breaking the tumor Glycocode
Feb 19, 2024 Since 2021 Gnubiotics has been developing a next generation of immunotherapy and now seeks to progress its lead candidate, GNU101, a promising glycopeptide therapeutic to the next step of IND approval and …See details»
Gnubiotics Sciences - Crunchbase Company Profile
Organization. Gnubiotics Sciences . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Gnubiotics Sciences is a biotechnology company based in Switzerland. ...See details»
Gnubiotics Sciences Sàrl - Swiss Biotech
Gnubiotics Sciences Sàrl . Swiss Biotech Association. Member. Profile ... Type of organization. Private company. Year of foundation. 2016. You May Also Be Interested In . Philip Morris …See details»
Gnubiotics Sciences Company Profile 2024: Valuation, Funding ...
Gnubiotics Sciences’s primary industry is Biotechnology. Is Gnubiotics Sciences a private or public company? Gnubiotics Sciences is a Private company. What is Gnubiotics Sciences’s …See details»
Gnubiotics Sciences SA Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Gnubiotics Sciences SA of Epalinges, VAUD. Get the latest business insights from Dun & Bradstreet.See details»
GNUbiotics Sciences - BioAlps
Organization Type . Private Company. Visit website Domains. COVID-Areas, Endocrine & Metabolic, Infectious Diseases, Oncology . Main sector. Biotech ... [email protected] . …See details»
Gnubiotics Sciences SA - LinkedIn
Gnubiotics Sciences SA, we’re exploring how glycan-programmed T cells can potentially improve outcomes for colorectal cancer patients.Our upcoming poster presentation at ESMO 2024 will …See details»
GNUBIOTICS at the Swiss Biotech Day
Gnubiotics Sciences SA, established in 2016, focuses on applying glycobiology to create unique therapeutics for unmet medical needs. Their GENESIS platform integrates four key …See details»
Gnubiotics Sàrl - VentureRadar
Gnubiotics was founded to apply a unique scientific understanding that nature is a reservoir of diverse glycans endowed with the potential to restore, renew and repair the microbiome. We …See details»
Gnubiotics Sciences SA - Venturelab
Aug 9, 2016 Gnubiotics Sciences SA is revolutionizing the microbiome health of humans and animals with a new category of complex molecules: glycans. Gnubiotics' unique and …See details»
Gnubiotics Sciences SA - startup.ch
Gnubiotics Sciences SA is revolutionizing the microbiome health of humans and animals with a new category of complex molecules: glycans. Gnubiotics' unique and proprietary technology …See details»
Gnubiotics Sciences Announces Funding from the Swiss …
Jul 6, 2022 Gnubiotics presented compelling data recently at the 2022 American Society of Clinical Oncology (ASCO) annual meeting showing the effect of its glycopeptides platform in …See details»
ADM Licenses Gnubiotics AMOBIOME for Global Use in Pet Food …
Apr 20, 2023 Gnubiotics has conducted extensive research on the safety and utility of animal milk oligosaccharides and achieved GRAS independent conclusions status in 2021. In …See details»
Gnubiotics to Present Data at the Annual Meeting of the American ...
May 27, 2022 Gnubiotics Sciences SA is a Swiss-based biotech company focused on the identification, characterization, and development of glycopeptides assets to tackle immune and …See details»
Gnubiotics attracts nobel prize winner as advisor ahead of clinical …
Aug 5, 2023 Gnubiotics will soon be starting preclinical trials of its first products designed for human therapeutic applications. A first product for animal health is already on the market. The …See details»
Meet Gnubiotics Science CEO and CSO Yemi Adesokan and …
Sep 13, 2021 Yemi Adesokan co-founded Gnubiotics Sciences, a Venture Leader Biotech that develops a solution for a healthier microbiome—an organ consisting of billions of microbes, …See details»
Gnubiotics Announces Self-Affirmed GRAS Designation of
Jul 12, 2021 Gnubiotics Sciences is a Swiss biotech company with a growing pipeline of microbiome targeted candidates designed for both animals and humans. Beyond its pipeline, …See details»
Gnubiotics: Microbiome innovation strategic partnership with ADM
May 9, 2022 In 2021, Gnubiotics also announced patents covering microbiome-based markers to predict, diagnose and treat feline obesity, a major cause of diabetes and chronic kidney …See details»
Gnubiotics gains allowance of patent of microbiome markers for ...
LAUSANNE, Switzerland, May 24, 2021 /PRNewswire/ -- Gnubiotics Sciences SA (Gnubiotics), a Swiss biotech company pioneering novel microbiome targeted solutions for humans and …See details»
Gnubiotics wins first commercial customer for AMOBIOME
Apr 21, 2023 Gnubiotics has conducted extensive research on the safety and utility of animal milk oligosaccharides and achieved GRAS independent conclusions status in 2021. In …See details»